Geode Capital Management LLC Has $818.32 Million Stake in IQVIA Holdings Inc. (NYSE:IQV)

Geode Capital Management LLC raised its stake in IQVIA Holdings Inc. (NYSE:IQV) by 1.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,175,524 shares of the medical research company’s stock after purchasing an additional 77,981 shares during the quarter. Geode Capital Management LLC owned 2.30% of IQVIA worth $818,315,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Pine Valley Investments Ltd Liability Co lifted its stake in IQVIA by 0.5% during the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 9,481 shares of the medical research company’s stock valued at $2,247,000 after acquiring an additional 50 shares in the last quarter. Howard Capital Management Inc. raised its holdings in shares of IQVIA by 4.9% in the fourth quarter. Howard Capital Management Inc. now owns 1,147 shares of the medical research company’s stock valued at $225,000 after purchasing an additional 54 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in IQVIA by 1.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 5,434 shares of the medical research company’s stock worth $1,068,000 after purchasing an additional 56 shares during the last quarter. Cypress Wealth Services LLC grew its position in IQVIA by 4.8% in the 4th quarter. Cypress Wealth Services LLC now owns 1,243 shares of the medical research company’s stock worth $244,000 after purchasing an additional 57 shares in the last quarter. Finally, Harbor Investment Advisory LLC increased its stake in IQVIA by 4.7% in the 4th quarter. Harbor Investment Advisory LLC now owns 1,286 shares of the medical research company’s stock valued at $253,000 after buying an additional 58 shares during the last quarter. Institutional investors own 89.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on IQV shares. Stephens assumed coverage on IQVIA in a research note on Friday, December 20th. They issued an “overweight” rating and a $250.00 target price on the stock. Citigroup cut their price objective on IQVIA from $225.00 to $210.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th. UBS Group lowered their target price on IQVIA from $260.00 to $255.00 and set a “buy” rating on the stock in a research note on Friday, February 7th. Robert W. Baird reduced their price target on shares of IQVIA from $212.00 to $210.00 and set a “neutral” rating for the company in a research report on Tuesday, January 21st. Finally, Truist Financial restated a “buy” rating and set a $263.00 price objective (up previously from $261.00) on shares of IQVIA in a report on Monday, February 10th. Five investment analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, IQVIA has an average rating of “Moderate Buy” and a consensus target price of $249.05.

IQVIA Trading Up 1.9 %

Shares of IQVIA stock opened at $174.52 on Thursday. The company’s 50-day moving average price is $191.43 and its 200-day moving average price is $204.92. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 2.12. IQVIA Holdings Inc. has a 12-month low of $169.11 and a 12-month high of $252.88. The company has a market cap of $30.77 billion, a price-to-earnings ratio of 23.27, a PEG ratio of 1.99 and a beta of 1.50.

IQVIA (NYSE:IQV) last announced its quarterly earnings results on Thursday, February 6th. The medical research company reported $2.90 EPS for the quarter, missing the consensus estimate of $3.11 by ($0.21). IQVIA had a net margin of 8.91% and a return on equity of 28.81%. On average, equities analysts expect that IQVIA Holdings Inc. will post 10.84 earnings per share for the current fiscal year.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.